BioBridges

What's new with BioBridges?

BioBridges is providing a San Francisco Bay Area-based biotech a CMC consultant to review and analyze the stability data for one of their programs as they approach an NDA submission this year.

For help managing your program or help supporting clinical development, connect with our team today:

BioBridges is providing a San Francisco Bay Area-based biotech with a CMC consultant | BioBridges BioBridges is providing a San Francisco Bay Area-based biotech a CMC consultant to review and analyze their stability data.

What's new with BioBridges?

BioBridges is providing a Cambridge-based biotech, a neurologist, to review and advise on preparing a grant focusing on a Phase 1 Alzheimer’s study. The client is focused on developing novel therapeutics that can effectively treat multiple types of cancer and neurodegenerative disorders.

For help managing your program or help supporting clinical development, connect with our team:

BioBridges provides a Cambridge-based biotech to advise on a Phase 1 Alzheimer's study | BioBridges BioBridges is providing a Cambridge-based biotech to advise on a Phase 1 Alzheimer’s study. Contact BioBridges for clinical support.

Our BioBridges team has had a great day connecting with other biopharmaceutical industry professionals. Thank you to everyone who stopped by the BioBridges booth!